Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3162914 | 1.00 | CYP3A4 (0.46) | CYP3A4KMT2AKDM4EALDH1A1KCNH2 | |
| SCHEMBL9356325 | 0.85 | CHRM2 (0.47) | KCNH2OPRK1OPRM1OPRD1SIRT1 | |
| SCHEMBL9356317 | 0.85 | CHRM2 (0.47) | KCNH2OPRK1OPRM1OPRD1SIRT1 | |
| SCHEMBL6685344 | 0.80 | MAPT (0.44) | ALDH1A1KCNH2OPRK1OPRM1OPRD1 | |
| SCHEMBL28842221 | 0.75 | KCNH2 (0.47) | KCNH2OPRK1OPRM1OPRD1SIRT1 | |
| SCHEMBL4399111 | 0.75 | CYP3A4 (0.48) | CYP3A4KMT2AKDM4EALDH1A1 | |
| SCHEMBL5954481 | 0.75 | CYP3A4 (0.48) | CYP3A4KMT2AKDM4EALDH1A1 | |
| SCHEMBL4616899 | 0.75 | CYP3A4 (0.48) | CYP3A4KMT2AKDM4EALDH1A1 | |
| SCHEMBL646159 | 0.75 | CYP3A4 (0.48) | CYP3A4KMT2AKDM4EALDH1A1OPRK1 | |
| SCHEMBL4399114 | 0.75 | CYP3A4 (0.48) | CYP3A4KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1658066-B9 | ADAMANTYLGLYCINE- BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV FOR THE TREATMENT OF DIABETES | BRISTOL MYERS SQUIBB CO (US) | 2010-02-24 | — | — | EP | disclosed |
| EP-1658066-B1 | ADAMANTYLGLYCINE- BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV FOR THE TREATMENT OF DIABETES | BRISTOL MYERS SQUIBB CO (US) | 2009-09-30 | — | — | EP | disclosed |
| EP-1997489-A1 | Adamantylglycine derivatives as inhibitors of dipeptidyl peptidase IV for the treatment of diabetes | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-12-03 | — | — | EP | disclosed |
| WO-2005012249-A2 | ADAMANTYGLYCINE- BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV FOR THE TREATMENT OF DIABETES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-02-10 | — | — | WO | disclosed |